A 6-year-old child presents with absence seizures (petit mal), occurring 10–15 times daily. The seizures are brief (5–10 seconds), with abrupt onset and offset, and no post-ictal confusion. Which antiepileptic drug is the first-line treatment for this seizure type?

Explanation

## Drug of Choice: Ethosuximide for Absence Seizures **Key Point:** Ethosuximide is the gold-standard first-line monotherapy for childhood absence seizures (petit mal), with efficacy rates >90% and a favorable safety profile specific to this seizure type. ### Why Ethosuximide? **High-Yield:** Ethosuximide is a **T-channel blocker** that selectively suppresses the 3 Hz spike-and-wave discharges characteristic of absence seizures. It has no efficacy against generalized tonic-clonic seizures and is ineffective for other seizure types. **Mechanism:** Ethosuximide blocks low-voltage-activated (L-type) calcium channels in the thalamus, interrupting the corticothalamic oscillations that generate absence seizures. ### Clinical Features Supporting Ethosuximide Choice | Feature | Ethosuximide | Valproate | Lamotrigine | Levetiracetam | |---------|--------------|-----------|-------------|----------------| | **Efficacy in absence** | **90%+** | ~80% | ~60% | ~40% | | **First-line status** | **Yes** | Alternative | Not preferred | Not preferred | | **Mechanism fit** | T-channel block | Broad spectrum | Broad spectrum | Unknown | | **Teratogenic risk** | Low | **Very high** | Low–moderate | Low | | **Drug interactions** | Minimal | Extensive | Moderate | Minimal | **Clinical Pearl:** Absence seizures are **NOT** responsive to phenytoin or carbamazepine (which block sodium channels). Using these agents alone will result in treatment failure. ### Dosing & Monitoring 1. **Initial dose:** 10–15 mg/kg/day in divided doses (typically 250 mg twice daily in children). 2. **Target:** 20–30 mg/kg/day (max 1.5 g/day). 3. **Monitoring:** Baseline CBC, LFTs; repeat at 3 months, then annually. Watch for GI upset, headache, hiccups (common), and rare agranulocytosis. **Warning:** Ethosuximide monotherapy is insufficient if the child also has generalized tonic-clonic seizures; dual therapy (ethosuximide + valproate or lamotrigine) is then required. ### Why Other Agents Are Not First-Line **Mnemonic:** **VEAL ChiPs** = **V**alproate, **E**thosuximide, **A**cetazolamide, **L**amotrigine are used in absence seizures, but **E**thosuximide is first-line; **ChiPs** = Carbamazepine, Phenytoin are **NOT** effective. [cite:Harrison 21e Ch 369; KD Tripathi 8e Ch 12]